|
ABOUT COMPANY
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, is focused on developing candidates for protease products in the fields of hemostasis and complement regulation. The company is headquartered in South San Francisco, California.
|
EARNINGS
Gross Profit (TTM): -40390000
Market Capitalization: 28708500
Operating Margin (TTM): -12.47
PE Ratio: None
PEG Ratio: 0.02
Profit Margin: 0
Revenue Per Share (TTM): 0.245
Revenue (TTM): 6929000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 1.574
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -3.055
Dividend Date: 2017-02-13
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -49865000
ExDividend Date: 2015-08-20
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|